Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rowley SD . Hematopoietic stem cell cryopreservation. In: Thomas ED, Storb R, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplantation, 2nd edn. Blackwell Scientific Inc: Malden, MA, USA, 1998, pp 481–492.

    Google Scholar 

  2. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J . Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991; 31: 521–526.

    Article  CAS  PubMed  Google Scholar 

  3. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998; 18: 4705–4708.

    CAS  PubMed  Google Scholar 

  4. Alessandrino EP, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L et al. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: analysis of 126 cases. Bone Marrow Transplant 1999; 23: 533–537.

    Article  CAS  PubMed  Google Scholar 

  5. Ferrucci PF, Martinoni A, Cocorocchio E, Civelli M, Cinieri S, Cardinale D et al. Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 2000; 25: 173–177.

    Article  CAS  PubMed  Google Scholar 

  6. Dhodapkar M, Goldberg SL, Tefferi A, Gertz MA . Reversible encephalopathy after cryopreserved peripheral blood stem cell infusion. Am J Hematol 1994; 45: 187–188.

    Article  CAS  PubMed  Google Scholar 

  7. Hoyt R, Szer J, Grigg A . Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000; 25: 1285–1287.

    Article  CAS  PubMed  Google Scholar 

  8. Higman MA, Port JD, Bezuchamp Jr NJ, Chen AR . Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000; 26: 797–800.

    Article  CAS  PubMed  Google Scholar 

  9. Bawens D, Hantson P, Laterre PF, Michaux L, Latinne D, Tourtchaninoff M et al. Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leuk Lymphoma 2005; 46: 1671–1674.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to F L Dulley.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Júnior, A., Arrais, C., Saboya, R. et al. Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion. Bone Marrow Transplant 41, 95–96 (2008). https://doi.org/10.1038/sj.bmt.1705883

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705883

This article is cited by

Search

Quick links